| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $16.8M | +26.8% |
| Cost of Revenue | $5.1M | +12.9% |
| Gross Profit | $11.7M | +34.1% |
| R&D Expense | $3.2M | +34.8% |
| SG&A Expense | $3.4M | +43.6% |
| Operating Income | -$1.9M | -60.4% |
| Pre-tax Income | $2.2M | +127.7% |
| Income Tax | $30K | +102.6% |
| Net Income | $2.1M |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.9M | -67.7% |
| Accounts Receivable | $1.2M | -13.7% |
| Current Assets | $4.3M | -58.9% |
| Total Assets | $27.5M | -21.3% |
| Current Liabilities | $4.8M | -42.6% |
| Long-term Debt | $1.0M | -47.3% |
| Total Liabilities | $7.2M | -58.8% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$134K | +86.5% |
| Capital Expenditures | $117K | +48.1% |
| Investing Cash Flow | -$195K | +95.7% |
| Financing Cash Flow | -$5.5M | -140.7% |
| Free Cash Flow | -$251K | +76.5% |
| +132.1% |
| EPS (Basic) | $0.21 | +114.3% |
| EPS (Diluted) | $0.20 | +113.6% |
| Stockholders' Equity |
| $20.4M |
| +15.8% |